Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @JahanMohiuddin
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JahanMohiuddin
-
Jahan Mohiuddin, MD proslijedio/la je Tweet
Great issue on
#HCC@JHepatology! Re: locoregional treatments article, it should have, at least, mentioned#SBRT, a highly effective treatment for#HCC@ldawsonmd@GI_RadOnc@lauren_henke@juanpabloarabhttps://www.journal-of-hepatology.eu/article/S0168-8278(19)30589-6/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Bladder sparing study (NCT03697850) phase II trial investigating atezolizumab as maintenance therapy in MIBC patients treated with chemo-radiotherapy is enrolling
@GroupeUNICANCER@AFUrologie@sfro_fr@PBlanchardMD@PaulSargospic.twitter.com/JnIbRebb1V
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Here are some thoughts on stats “vs” ML. Rel btwn the fields, why debates on topic are almost always fundamentally flawed, why I think there’s so much talking past each other, and why I wish we could focus instead on *specific* methods + problems https://sgfin.github.io/2020/01/31/Comments-ML-Statistics/ … 2/3
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial https://www.redjournal.org/#/article/S0360-3016(19)34512-2/fulltext …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
SABR for spinal mets—the need-to-know points for the modern oncologist. A novel, effective and personalized approach https://ja.ma/37AULOF
#SABR#cancerHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Are you confused by all the recently published gyn onc trials for uterine cancer? In this review,
@ANViswanathanMD and I describe modern radio therapeutic management of gyn cancers. Check out this reference chart for recently published RCTs. https://authors.elsevier.com/a/1a43U_KEwZuUb-#.XdRTwFZJvtc.twitter …pic.twitter.com/Uj9dExAfZ5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks
@PennMedicine for making the responsible choice!pic.twitter.com/uOSnBa1Dbx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Thank you to
@SenatorBurr,@SenStabenow,@michaelcburgess, and@DevinNunes for supporting#RadOnc community concerns about proposed Medicare alternative payment model. Read the series of oversight letters to@CMSGov: http://ow.ly/AWKw50xaWIk pic.twitter.com/JDw5LlXcQC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Loved speaking at our
#WomenInMedicine @PennCancer event led by @CharuAggarwalMD and these two Neha Vapiwala and Lynn Schuchter - two of the great mentors and sponsors of our generation @PennMedicinepic.twitter.com/ZsXe8hXdQb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Joint
@RRS_RadRes@the_RSS Session on#FLASH_RT at#RADRES2019 Dr Koumenis @@Penn team leading the way in using#protontherapy at ultra high dose rate for this. Normal tissues are spared but no sparing of tumor in their model.pic.twitter.com/HjKnPSvkJq
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Very impressive work on
#FLASH_RT at@Penn#radonc

#RADRES2019pic.twitter.com/Htqb4LqKOF
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
BREAKING: ASTRO expresses strong support for the nomination of
#RadOnc Stephen Hahn as@US_FDA Commissioner. Read our full statement here: http://ow.ly/uBhO50wZC4m#FDA#FDACommissionerpic.twitter.com/GesiqNUuig
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MGH ID team publishes about their fatal FMT complication. Microbiome modulation is a new frontier of medicine with so much promise but need careful patient selection to ensure benefit > risk. https://www.nytimes.com/2019/10/30/health/fecal-transplant-death.html?smid=nytcore-ios-share … via
@nytimesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
BREAKING: Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting processhttps://buff.ly/2nrrEvL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
Several great candidates, but excited to see the awesome
@SteveHahnMD on the list! Incredible leader who would serve the public’s interest brilliantly in this role.#radonc@ASTRO_org@MDAndersonNewshttps://twitter.com/WSJ/status/1169401026337792000 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
#OncoAlert#Lungcancer#radonc#LCSM -Early-phase#clinicaltrial out of UPenn -Nelfinavir was identified in the lab as a radiosensitizer -In stage III#NSCLC, with 66 Gy#radiotherapy and standard chemo it achieved 94% response, favorable locoregional control and survivalhttps://twitter.com/JAMAOnc/status/1164658506496184322 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jahan Mohiuddin, MD proslijedio/la je Tweet
In properly selected patients, less is more. De-intensification of chemoXRT in
#HPV associated#oropharynx cancer shows promising results.#radonchttps://bit.ly/2KTUKv8Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Important point that TORS was (rightly) the experimental therapy here, and the trial was powered to show a 10 pt swallow improvement with TORS. Results showed the opposite at 1 year, but will require longer follow up and bigger phase 3.
#hncsm#radonchttps://twitter.com/nicholslab1/status/1161098702347485184 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you for this great essay
@EricTopol. Great vision for an effective physician organization that can advocate for doctors and patients as we enter an age of AI. Will determine whether AI-enabled efficiencies lead to more time with each patient or just more patients per day.https://twitter.com/EricTopol/status/1158365649694887938 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#radonc residents see this short video for the best explanation of the differences between radiation units of measurement! Thank you@iaeaorg Cc@ARRO_orghttps://twitter.com/iaeaorg/status/1155114120208932867 …
2:10Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.